Watching Stereotaxis; Hearing B. Riley Sets Buy Rating, $5.50 Price Target
Portfolio Pulse from Benzinga Newsdesk
B. Riley has set a Buy rating and a $5.50 price target for Stereotaxis (STXS), a medical technology company.
May 19, 2023 | 5:41 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Stereotaxis receives a Buy rating and a $5.50 price target from B. Riley, indicating a positive outlook for the stock.
The Buy rating and $5.50 price target set by B. Riley for Stereotaxis (STXS) indicates a positive outlook for the stock in the short term. This recommendation is likely to attract investors and drive the stock price up.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100